You have 9 free searches left this month | to do more

pasireotide

Pasireotide is a drug used to treat Acromegaly, Cushing's Disease, Neuroendocrine Tumors, and other conditions. Pasireotide is being actively studied in 2 studies and prior, has been studied in 21.

Top SponsorsTop SitesTop Investigators
Novartis PharmaceuticalsNovartis Investigative SiteAnthony Sung, MD
Emory UniversityStanford University Medical Center Stanford Cancer Center (3)Bassel El-Rayes
Alliance Pour La Recherche en CancerologieBaylor College of MedicineElisabeth Heath
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
U
Withdrawn
  • Gastro-enteropancreatic Neuroendocrine Tumor
  • (no location specified)
2022-02-17
Feb 17, 2022
A
Completed
  • Hematological Malignancies
  • Pasireotide
  • Boston, Massachusetts
  • +1 more
2021-10-19
Oct 19, 2021
U
Completed
  • Hyperinsulinemic Hypoglycemia
  • Post Gastrointestinal Tract Surgery Hypoglycaemia
  • Pasireotide
  • Aurora, Colorado
    University of Colorado Denver
2021-09-27
Sep 27, 2021
N
N
Completed
  • Hepatic Cirrhosis
  • Alcoholism
  • Pasireotide
  • Richmond, Virginia
  • +3 more
2020-12-17
Dec 17, 2020
B
Completed
  • Adenocarcinoma of the Prostate
  • +3 more
  • Detroit, Michigan
    Barbara Ann Karmanos Cancer Institute
2021-03-02
Mar 2, 2021
H
Active, not recruiting
  • Pancreatic Fistula
  • Pancreatic Neoplasms
  • Helsinki, Finland
    Helsinki University Central Hospital
2020-08-21
Aug 21, 2020
M
Available
  • Congenital Hyperinsulinism
  • Pasireotide
  • Bronx, New York
    Montefiore Medical Center
2021-07-19
Jul 19, 2021
N
Completed
  • Cushing Disease
  • Pasireotide
  • Boston, Massachusetts
  • +7 more
2021-05-06
May 6, 2021
N
Completed
  • Carcinoid Tumor
  • Acromegaly
  • Pasireotide
  • Los Angeles, California
  • +16 more
2020-12-17
Dec 17, 2020
R
Active, not recruiting
  • Cushing's Disease
  • +8 more
  • La Jolla, California
  • +93 more
2020-10-30
Oct 30, 2020
H
Completed
  • Healthy
  • Nottingham, United Kingdom
    Quotient Sciences
2020-10-26
Oct 26, 2020
E
Completed
  • Neuroendocrine Tumors
  • Pasireotide
  • +2 more
  • Atlanta, Georgia
    Emory University Winship Cancer Institute
2018-10-16
Oct 16, 2018
S
Terminated
  • Castrate Resistant Prostate Cancer
  • +2 more
  • Pasireotide
  • +2 more
  • New Haven, Connecticut
  • +1 more
2018-04-23
Apr 23, 2018
C
Withdrawn
  • Ectopic ACTH Syndrome
  • Pasireotide
  • Los Angeles, California
    Cedars-Sinai Medical Center
2018-01-24
Jan 24, 2018
A
Completed
  • Breast Cancer
  • PASIREOTIDE
  • PLACEBO
  • Paris, France
  • +1 more
2017-01-24
Jan 24, 2017
S
Terminated
  • Nelson Syndrome
  • Pasireotide
  • London, United Kingdom
  • +3 more
2016-11-01
Nov 1, 2016
U
Completed
  • Non-functioning Pituitary Adenomas
  • Prolactinomas
  • Rio de Janeiro, RJ, Brazil
    Endocrinology Section - Hospital Universitário Clementino Fraga
2016-07-21
Jul 21, 2016
U
Completed
  • Advanced Adult Hepatocellular Carcinoma
  • Tampa, Florida
  • +2 more
2016-03-08
Mar 8, 2016
R
Completed
  • Angiodysplasia
  • Pasireotide
  • Placebo
  • Paris, France
    Société Française d'Endoscopie Digestive (SFED)
2015-12-04
Dec 4, 2015